SurgEase Innovations

What SurgEase Innovations does

SurgEase Innovations Ltd is a UK-based medical technology company founded in 2016 and headquartered in Maidenhead, England. The company designs, manufactures, and sells clinician-led surgical devices focused on colorectal diagnostics and cancer care pathways. Its core hardware products include the LumenEye X1, a portable digital rectoscope providing Full HD imaging for point-of-care colorectal diagnosis, and TriEye, described as the world's first tri-camera digital anoscope with three strategically positioned HD cameras for multi-planar visualization. These devices are integrated with the CHiP cloud-based software platform, which manages surgical image capture, workflow, tele-proctoring, and EHR integration, alongside CHiP Lite (a portable variant with NFC/5G connectivity) and the Mentor training platform for clinical case review.

The company operates a B2B enterprise sales model targeting NHS hospital trusts, Primary Care Networks, and international healthcare systems. Revenue is generated through hardware sales (LumenEye X1, TriEye devices) bundled with CHiP software licensing on multi-year contracts, supplemented by professional services and training. Distribution channels include NHS Supply Chain DPS framework agreements, direct enterprise sales, and international distributor networks. SurgEase has established named partnerships with major NHS trusts including King's College Hospital, Royal Marsden, University Hospitals of North Midlands, and Buckinghamshire Healthcare, plus international partners including Mount Sinai Health System (US), Amsterdam UMC, Bordeaux University Hospital, and Imperial College London.

The company maintains regulatory certifications including FDA 510(k) clearance for LumenEye X1 (US market entry enabled), ISO 13485 medical device quality management, ISO 27001:2022 information security, NHS DSPT Toolkit compliance, and Cyber Essentials Plus. Founded by former colorectal surgeon Fareed Iqbal, SurgEase positions itself on clinician-led product development and has generated peer-reviewed clinical evidence across multiple international centers demonstrating cost savings, safety, and outcomes improvements in colorectal diagnostic workflows.

Name

SurgEase Innovations

Legal name

SurgEase Innovations Ltd

Website

https://surgease.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

SurgEase Innovations is a UK-based medical technology company that designs, manufactures, and sells clinician-led surgical devices and software (LumenEye X1, TriEye, CHiP platform) for colorectal diagnostics and cancer pathways, serving NHS trusts, Primary Care Networks, and international healthcare systems.

Ownership category

akta.pro rank

Product category

Surgical Endoscopy Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)

SIC

Surgical & Medical Instruments & Apparatus (3841), Optical Instruments & Lenses (3827)

akta.pro primary industry

Endoscopy Systems & Accessories (Scopes, Cameras, Light Sources, Insufflation) (HLAHADAB)

akta.pro secondary industries

Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH), Medical Device Connectivity & Interoperability Middleware (MDI, EHR/HL7/FHIR Integration) (HLACAPAJ), Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

Keywords

• Colorectal endoscopy devices
• Surgical imaging hardware
• Digital rectoscopy systems
• Surgical workflow software
• Hospital endoscopy equipment

Headquarters

HQ city

Nelson

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Others

Revenue model

1. Medical Device Hardware Sales: Sale of LumenEye X1 and TriEye endoscopic devices to NHS trusts, hospitals, and healthcare systems. One-time hardware purchase with accompanying software license.
2. Software Platform Licensing (CHiP): CHiP and CHiP Lite software platform licensing for surgical image capture, workflow management, and collaboration. Subscription or licensing model supporting cloud storage and remote proctoring features.
3. NHS Supply Chain Framework: Products available through NHS Supply Chain DPS framework enabling procurement by NHS trusts. Framework agreement providing recurring revenue through repeat orders.
4. Professional Services and Training: Training hub (Mentor platform) for clinical teams. Implementation support and ongoing technical assistance for product deployment.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

SurgEase Innovations designs, manufactures, and sells clinician-led medical devices and software for colorectal diagnostics and surgical workflow. Its flagship hardware is the portable LumenEye X1 digital rectoscope and the TriEye triple-camera digital anoscope, both paired with the CHiP cloud platform for image capture, tele-proctoring, and clinical workflow management. The company also offers CHiP Lite (a portable software/recording unit) and the Mentor training hub, sold to NHS trusts, PCNs, and international healthcare systems.

Product overview

SurgEase Innovations offers a portfolio of clinician-led medical technology products comprising hardware devices and software platforms. The core hardware products are LumenEye X1 (portable digital rectoscope) and TriEye (tri-camera digital anoscope), both providing HD imaging for colorectal diagnostics at point of care. These are powered by the CHiP software platform, which serves as the central orchestration layer for image capture, data management, tele-proctoring, and clinical workflow. CHiP Lite provides a streamlined, mobile variant of the software, while Mentor delivers training and case review capabilities. The portfolio enables rapid diagnosis, secure data handling, remote collaboration, and clinical training across hospital and community settings.

Differentiator

Problem solved

Functional benefit

Brands

• LumenEye: Portable digital rectoscope enabling rapid, real-time colorectal diagnosis. Includes LumenEye X1 system.
• CHiP
• CHiP Lite
• TriEye
• Mentor

Products and services

• LumenEye X1 Digital Rectoscope A portable digital rectoscope system enabling rapid, real-time colorectal diagnosis at point of care. Includes an HD endoscope, tablet display, integrated CHiP software, and a portable workstation designed for use in outpatient clinics, hospital theatres, and community diagnostic settings. Targeted at NHS trusts, primary care networks, and international hospitals performing colorectal assessment and surveillance.
• TriEye Triple-Camera Digital Anoscope World's first triple-camera digital anoscope with three HD cameras (forward-facing, axial, retroflex) providing complete digital visualization of the anorectal complex at point of care. Patented sheath design includes soft-touch capture buttons, 100ml insufflation bellows with intelligent air-sealing, and wide access port compatibility. Sold to colorectal surgeons and hospitals for advanced anoscopic assessment.
• CHiP Surgical Image Capture and Workflow Platform Cloud-based platform for surgical image capture, workflow management, tele-proctoring, and collaboration. Includes HD media export, live broadcast streaming with annotation overlay, secure remote proctoring, and integration with hospital EHR systems. Sold as a software license/subscription bundled with SurgEase hardware for NHS trusts, hospitals, and clinical training programs.
• CHiP Lite Portable Recording Unit Lightweight, trolley-free portable recording unit paired with a streamlined version of the CHiP software for fast, secure patient pathway coordination. Features integrated NFC card reader, 5G connectivity backup, plug-and-play deployment, and HIPAA and GDPR-compliant cloud storage. Sold to clinical teams needing recording and collaboration capabilities without complex IT infrastructure.
• Mentor Training Hub Training hub platform for clinical teams to review cases, access on-demand training content, improve surgical skills, and complete feedback forms. Sold to surgical training programs, fellowship schemes, and continuous professional development initiatives for colorectal surgery.

Quantifiable outcome

• Reduced NHS waiting times by up to 70 weeks for low-risk patients through community bowel clinics
• +5 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

16 partnerships are on record, tiered minor, core and flagship.

• BMJ Open (Study Publication)minorStrategic or Co-development Partner · 1 January 2026Economic evaluation study published in BMJ Open comparing LumenEye digital proctoscopy to flexible sigmoidoscopy. Study used real-world NHS data from 177 procedures demonstrating £820 cost savings per patient over 2-year Watch-and-Wait surveillance.
• Buckinghamshire Healthcare NHS TrustcoreStrategic or Co-development Partner · 1 January 2025Clinical partnership evaluating LumenEye safety and feasibility in outpatient colorectal clinic setting. Study analyzed 327 LumenEye procedures demonstrating strong safety profile, high tolerability, and low missed pathology rate. Results published in Techniques in Coloproctology.
• Mount Sinai Health SystemflagshipStrategic or Co-development Partner · 1 January 2025First US LumenEye procedure performed at Mount Sinai in New York by Dr. Patricia Sylla, marking US market entry. Key opinion leader partnership for US market development and clinical adoption. CEO traveling to support additional US center deployments.
• European Society of Coloproctology (ESCP)coreGTM or Marketing Partner · 1 January 2025Sponsorship of 2025 ESCP Tripartite Colorectal Meeting Hands on Course on Watch and Wait. Event held at Palais des Congrès in Paris, France on September 9, 2025. Company supports educational initiatives advancing minimally invasive colorectal cancer care.
• Bordeaux Colorectal Institute AcademycoreStrategic or Co-development Partner · 1 January 2025International clinical research partnership for LUMEVAL study assessing LumenEye for tumor response in rectal cancer after neoadjuvant treatment. Prospective international cohort study at expert colorectal centers.
• Maastro (Maastricht Radiation Oncology)minorStrategic or Co-development Partner · 1 January 2025Clinical trial partnership evaluating Maastro applicator for HDR brachytherapy in rectal cancer using LumenEye visualization. Interventional pilot trial NCT06087718 assessing feasibility of organ-preserving treatment.
• Amsterdam UMCcoreStrategic or Co-development Partner · 1 January 2025International academic medical center partnership for colorectal research and clinical application of SurgEase technologies. Logo partner displayed on company website indicating ongoing collaborative relationship.
• King's College Hospital NHS Foundation TrustcoreStrategic or Co-development Partner · 1 January 2025Major NHS trust partnership for colorectal surgery innovation. Logo partner displayed on company website indicating ongoing collaborative relationship and clinical adoption.
• Imperial College LondoncoreStrategic or Co-development Partner · 1 January 2025Academic partnership with leading UK university for research and development in surgical technology. Logo partner displayed on company website indicating collaborative relationship.
• The Royal Marsden NHS Foundation TrustcoreStrategic or Co-development Partner · 1 January 2025Partnership with world's leading cancer hospital for colorectal cancer care and research. Logo partner displayed on company website indicating ongoing collaborative relationship.
• Bordeaux University Hospital (CHU Bordeaux)coreStrategic or Co-development Partner · 1 January 2025International university hospital partnership for colorectal research. Logo partner displayed on company website. Active collaboration on LUMEVAL international study.
• NHS Supply Chain (DPS)coreChannel Partner/ Reseller/ Distributor · 1 January 2024SurgEase is an approved supplier on the NHS Supply Chain Dynamic Purchasing System for Medical Technology Innovation. This framework agreement enables NHS trusts across England to procure SurgEase products including LumenEye through compliant public sector purchasing channels. The partnership includes social value commitments with specific environmental and ethical targets.
• Central Camden PCNcoreStrategic or Co-development Partner · 1 January 2024Primary Care Network partnership for community bowel clinic using LumenEye. Clinic cut patient waiting times by up to 70 weeks for low-risk patients, with estimated £250,000 savings for North Central London ICB. Demonstrates community-based care model.
• University College London Hospitals Foundation TrustcoreStrategic or Co-development Partner · 1 January 2024Partner in community bowel clinic pilot alongside Central Camden PCN. Clinical oversight and governance support for community-based LumenEye diagnostic service. Helps reduce secondary care referral burden.
• University Hospitals of North Midlands NHS TrustflagshipStrategic or Co-development Partner · 1 January 2023Collaboration on dual-procedure mobile endoscopy unit delivering over 725 appointments monthly to address overdue surveillance cases. Partnership shortlisted for HSJ Partnership Awards 2023 in Best Elective Care Recovery Initiative category. Combines SurgEase technology with Trust clinical expertise.
• MedinetflagshipStrategic or Co-development Partner · 1 January 2023Three-way partnership with University Hospitals of North Midlands NHS Trust and Medinet to deliver mobile endoscopy services using SurgEase technology. Medinet provides clinical staffing and operational support alongside the technology platform.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Ambu: Ambu is a leading manufacturer of single-use endoscopes, including the aScope family for GI and airway procedures. Like SurgEase, Ambu focuses on portable, point-of-care endoscopy designed to displace reusable stack-based systems, addressing similar clinical workflow pain points in outpatient and community settings.

Broad incumbents

• Karl Storz: Karl Storz is a global leader in rigid and flexible endoscopy with deep hospital installed bases across surgical specialties. As a broad incumbent in endoscopy systems and accessories, it competes indirectly with SurgEase in colorectal and anoscopy workflows while offering a much wider portfolio across specialties.
• Olympus Medical Systems: Olympus is the dominant player in GI endoscopy with the broadest installed base of flexible endoscopes and processors globally. While Olympus does not specialize in portable rectoscopes for community settings, its scale and channel access position it as the primary incumbent threat to SurgEase's NHS and US commercialization.
• Pentax Medical (HOYA): Pentax Medical manufactures flexible endoscopy systems widely used in gastroenterology and colorectal screening. It is a broad incumbent competitor in endoscopic imaging whose established hospital relationships overlap with SurgEase's target procurement accounts.
• Fujifilm Healthcare: Fujifilm's healthcare division offers endoscopy processors, scopes, and increasingly AI-enhanced imaging platforms used in GI workflows. As a broad incumbent, Fujifilm competes indirectly through hospital endoscopy suite upgrades and colorectal screening programs.
• Stryker: Stryker operates broadly across surgical devices, visualization, and endoscopy. While not a specialist in lower-GI portable endoscopy, its integrated OR and surgical visualization portfolios compete for the same hospital capital budgets as SurgEase.
• STERIS: STERIS provides endoscopy processing, storage, and single-use accessory solutions alongside broader infection prevention and surgical equipment. It is a broad incumbent whose endoscopy consumables and reprocessing offerings overlap with SurgEase's disposable sheath and reprocessing workflow.
• Boston Scientific: Boston Scientific has a substantial GI and colorectal franchise including resection, hemostasis, and surveillance tools. As a broad incumbent across multiple procedural categories, it competes indirectly with SurgEase for colorectal surgeon mindshare and hospital budget.

Emerging players

• Interscope: Interscope develops disposable endoscopic devices for GI tract procedures, including lower GI applications. As an emerging player focused on single-use endoscopic solutions, it shares SurgEase's strategic thesis of displacing reusable endoscopy stacks in outpatient and ambulatory settings.
• Virgo Surgical Video Solutions: Virgo provides cloud-based video capture, AI analysis, and workflow software for endoscopy procedures. It shares SurgEase's CHiP platform thesis of integrating hardware-agnostic software with endoscopic image capture to improve quality, training, and procedure documentation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/surgease
• LinkedInlinkedin.com/company/surgease-innovations

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SurgEase Innovations